Skip to content

Homoeopathic treatment of urticaria

A double-blind, randomized, placebo-controlled trial of individualized homoeopathic medicines in improving the quality of life in adults with chronic spontaneous urticaria - N/A

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064631
Enrollment
50
Registered
2024-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L501- Idiopathic urticaria

Interventions

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within
dosage and repetition will be maintained depending upon the individual requirement of the cases. All sundry items will beprocured from a Good Manufacturing Practice (GMP) certified firm. All the enrol

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of chronic urticaria diagnosed clinically. (EB00.1 is the ICD-11 code) 2.Patients having UAS7 score mild 7-15; moderate 16-27 3.Patients of either sex or transgenders. 4.Patients of the age between 18 and 65 years. 5.Participants having prior experience or knowledge of the treatment. E.g.- primed to expect ‘homoeopathic aggravation’ and available treatment options for the disease conditions, intimated through Patient Information Sheet.

Exclusion criteria

Exclusion criteria: 1.Participation having UAS7 score: less than 7 and more than 27 2. Participation in a clinical trial within the last 3 months. 3. Non Providing written informed consent voluntarily. 4. Patients using regular conventional anti-allergic medication and/or glucocorticoid steroids. 5. Vulnerable population- Unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, mentally incompetent people. 6. Patients having history of severe anaphylactic shock. 7. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. 8. Pregnancy, puerperium, lactation. 9. Patient under tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence. 10.Self-reported immune-compromised state AIDS, Hepatitis &c. 11.Undergoing homoeopathic treatment for any chronic disease within last 6 months.

Design outcomes

Primary

MeasureTime frame
Chronic Urticaria Quality of Life (CU-Q2oL) questionnaireTimepoint: Every month up to 3 months

Secondary

MeasureTime frame
Measure Yourself Medical Outcome Profile version 2 (MYMOP-2)Timepoint: Every month up to 3 months;Urticaria Control Test (UCT)Timepoint: Every month up to 3 months

Countries

India

Contacts

Public ContactDr Arpita Basu

D. N. De Homoeopathic Medical College and Hospital

drarpitasen@gmail.com9830273374

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026